Abbott (NYSE:ABT) won FDA approval for the latest in its line of peripheral vascular intervention devices, the Omnilink Elite balloon-expandable stent system.
Structural Heart
MassDevice.com +3 | The top 3 med-tech stories for August 1, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
UPDATE: Edwards responds to British Medical Journal analysis
Edwards Lifesciences slides, rebounds on negative heart valve study
UPDATED August 1, 2012 with comments from Edwards Lifesciences re. Dr. Martin Leon
TAVI: Boston Scientific says it will take longer, cost more to bring Lotus valve system to market
Boston Scientific (NYSE:BSX) said it will take longer and cost more money to get its transcatheter aortic valve replacement product to market.
MassDevice.com +3 | The top 3 med-tech stories for July 25, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Sapien sales drive Edwards’ gains in Street-beating Q2
Edwards Lifesciences (NYSE:EW) reaped the rewards of its Sapien heart valve during the 2nd quarter, posting a nearly 17% increase in profits on a 12% sales hike, that sent its stock up nearly 6% this morning.
MassDevice.com +3 | The top 3 med-tech stories for July 18, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Medtronic launches CoreValve trial
Cook Medical lands FDA win for Evolution colonic stent | Regulatory Roundup
Cook Medical touts FDA win for next-gen colonic stent
Cook Medical won FDA clearance for the latest of its Evolution line, the Colonic Controlled-Release stent.
Podcast: Conquering venous disease with Veniti founder and chief Sean Morris
Veniti founder, president & CEO Sean Morris is on the march, looking to take over venous disease treatment with a suit of specialized devices that he hopes will knock out their more generic forebears.
Veniti, formed in 2009, specializes in devices for the venous anatomy, an arena often covered in a larger medical device company’s vascular devices business.